Zimmer Biomet Inc.

ZBH | NYSE

Price Alert Chart Builder DCF Calculator

$94.32

-$1.04 (-1.09%)

At close: Sep 21, 2026, 4:00 PM ET

$94.32

$0 (0.00%)

After-hours: Sep 21, 2026, 4:08 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

-1.09%

(1D)

Rating

Updated: Aug 25, 2026

53.7

Fundamentals Strong

Market Sentiment Neutral

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $18.25B

1D Range

93.64 94.73

52W Range

79.12 106.88

Valuation (TTM)

PE 22.95

PB 1.45

EV/EBITDA 12.93

Valuation (NTM)

Forward PE 10.17

Forward PEG 3.68

Price Target $103.11

Cash Flow

FCF Yield 12.3%

SBC Adj. FCF Yield 11.7%

SBC Impact -5.4%

Margins

Gross Margin 69.9%

Operating Margin 15.7%

FCF Margin 26.5%

Growth (CAGR)

Revenue 3Y | 5Y 5.8% | 2.9%

Dil EPS 3Y | 5Y 19.5% | -1.2%

FCF 3Y | 5Y 29.8% | 11.0%

Returns

ROA 3.5%

ROE 6.4%

ROIC 5.5%

Financial Health

Net Debt

$7.07B

Current Ratio 1.69

Interest Coverage 4.63

Dividends

Div Yield 1.02%

Payout Ratio 23.4%

FCF Payout Ratio 10.4%

All Key Statistics

Loading financial charts...

Profile

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products,...

Sector Healthcare

Industry Medical - Devices

Employees 17,000

IPO Date Jul 24, 2001

Website www.zimmerbiomet.com

Fiscal Year January - December

Full Company Profile

Latest News

4 days ago · zacks.com

Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

13 days ago · gurufocus.com

Is Zimmer Biomet Holdings Inc (ZBH) a Bargain After 3.9% Drop? GF Value Says Undervalued

On September 08, 2026, Zimmer Biomet Holdings Inc (ZBH) shares fell 3.9% to a current price of $94.22. This decline comes amid a 52-week price range of $79.12 t

14 days ago · prnewswire.com

Zimmer Biomet Announces Americas Leadership Promotions to Accelerate Commercial Transformation

Gary Campbell promoted to President, Americas Brian Hatcher promoted to President, Recon, S.E.T., CMFT, Neuro and Biosurgery Bradley Kessler promoted to President, Americas – Robotics, Technology and Data WARSAW, Ind.

18 days ago · zacks.com

Why Is Zimmer (ZBH) Up 1.8% Since Last Earnings Report?

Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?

21 days ago · seekingalpha.com

Zimmer Biomet - Showing Signs Of Life

Zimmer Biomet is seeing structural constant currency sales growth appear. This is driven by transformation factors, R&D and M&A efforts. Earnings growth is lagging sales, but this hopefully should catch up soon.

22 days ago · zacks.com

Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

25 days ago · prnewswire.com

Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2026

WARSAW, Ind., Aug. 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2026.

1 month ago · zacks.com

Is Zimmer Biomet Stock Worth Retaining in Your Portfolio Now?

ZBH's growth outlook is backed by healthy procedure demand and Z1, HAMMR and OrthoGrid adoption, though debt and competition remain concerns.

1 month ago · zacks.com

Here's Why Zimmer Biomet (ZBH) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.